Genetic susceptibility to systemic sclerosis. From clinical aspect to genetic factor analyses

INSERM, U906, Marseille, F-13385, France.
European Journal of Internal Medicine (Impact Factor: 2.89). 06/2009; 20(3):242-52. DOI: 10.1016/j.ejim.2008.07.012
Source: PubMed


Systemic sclerosis is a rare autoimmune disease mainly characterized by vascular alteration and fibrosis involving skin but also visceral organs such as lungs, digestive tract, and heart. This disease leads to high morbidity and mortality. Its pathogenesis remains unclear, but recent attention has focus on genetic factors.
We first recall the main manifestations associated with systemic sclerosis and leading to its diagnosis and prognosis. Then we propose an overview on human genetics studies, as a number of genetic loci have been identified that appear to be associated with the disease.
Articles concerning association studies with candidate genes encoding for extracellular matrix proteins, cytokines, growth factors, chemokines, and proteins involved in vascular tone and immune regulations are presented and discussed.
Systemic sclerosis is a multigenic complex disorder. Genetic associations are observed in distinct phenotypes such as the diffuse cutaneous form or the limited form, or in association with specific autoantibody pattern. Promising candidate genes are those involved in pathways that lead to the vascular damage and fibrosis. A better knowledge of crucial mediators involved in systemic sclerosis could in the future provide new therapeutic strategies to control the disease.

Download full-text


Available from: Christophe Chevillard, Feb 03, 2015
  • [Show abstract] [Hide abstract]
    ABSTRACT: To investigate the possible implication of the matrix metalloproteinase-12 (MMP-12) gene in the genetic predisposition to systemic sclerosis (SSc) susceptibility and clinical phenotype. The MMP-12 rs2276109 A/G functional polymorphism was selected as a genetic marker and genotyped by polymerase chain reaction-restriction fragment length polymorphism assay in 513 unrelated subjects of Italian white ancestry: 250 patients with SSc [146 limited cutaneous SSc (lcSSc), 104 diffuse cutaneous SSc (dcSSc)] and 263 healthy individuals. A significant difference was observed in MMP-12 rs2276109 genotype distribution between patients with SSc and controls (p = 0.0003), and between lcSSc and dcSSc (p = 0.003). The A allele frequency was significantly higher in patients with SSc than in controls (p = 0.0002), and higher in dcSSc than in lcSSc (p = 0.003). After adjustment for age and sex, the homozygosity for the A allele significantly influenced the predisposition to SSc and to dcSSc (OR 2.44, 95% CI 1.61-3.71, p < 0.0001; OR 4.69, 95% CI 2.36-9.33, p < 0.0001, respectively). A trend toward an association between the AA genotype and lcSSc was observed (p = 0.06). The homozygosity for the A allele was also significantly and independently associated with antitopoisomerase I antibody positivity (OR 6.39, 95% CI 2.18-18.76, p = 0.001) and interstitial lung disease (OR 2.94, 95% CI 1.25-6.95, p = 0.01). The MMP-12 rs2276109 gene polymorphism may contribute to susceptibility to SSc, and in particular to dcSSc and pulmonary fibrosis.
    The Journal of Rheumatology 09/2010; 37(9):1852-7. DOI:10.3899/jrheum.100237 · 3.19 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Due to its high association with Raynaud's phenomenon systemic sclerosis (SSc) is probably the most common connective tissue disease seen by vascular specialists. In part 1 of our systematic overview we summarize classification concepts of scleroderma disorders, the epidemiologic and genetic burden, the complex pathophysiologic background, and the clinical features and the stage-dependent capillary microscopic features of SSc. Furthermore, we address the diagnostic recommendations propagated by the German Network for Systemic Sclerosis and the Task Force for Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology, the European Respiratory Society, and the International Society of Heart and Lung Transplantation.
    VASA.: Zeitschrift für Gefässkrankheiten. Journal for vascular diseases 01/2011; 40(1):6-19. DOI:10.1024/0301-1526/a000065 · 1.00 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Inflammatory disorders of the skin, including eczematous, psoriasiform, lichenoid-interface, ­autoimmune, and neutrophilic dermatoses, probably represent the group of cutaneous diseases in which molecular pathology currently has the least impact in daily clinical practice. Many of these diseases are readily diagnosed through the correlation of clinical features with histopathological findings on hematoxylin and eosin (H + E)-stained tissue sections. In general, microscopic pattern analysis offers a very useful and reliable method to diagnose inflammatory skin diseases. The application of additional histochemical stains, immunohistochemistry, and/or immunofluorescence analysis is occasionally required. However, in some instances, diagnostic difficulties do arise. For example, the clinical and/or microscopic distinction of allergic contact dermatitis (ACD) from irritant contact dermatitis (ICD), pompholyx (dyshidrotic eczema) from pustular psoriasis, and even classic chronic psoriasis from chronic atopic dermatitis (AD) may be challenging. Although chronic psoriasis and AD show distinct differences with respect to cytokine milieu (i.e., Th1 in AD vs. Th2 in psoriasis), bacterial superinfection, surface pH, transepidermal water loss and itch, it is well known that these disorders share many morphological and molecular features [1, 2]. For example, from a dermatopathologist’s perspective, the lesional skin of both conditions can ­demonstrate the presence of T-cell and CD1a+/CD11c+ dendritic cell infiltrates associated with hyperplasia/altered differentiation of keratinocytes [1, 2]. In addition, cutaneous T-cell dyscrasias (i.e., lymphomas) can occasionally masquerade, both clinically and histopathologically, as inflammatory dermatoses (i.e., cutaneous lupus erythematosus) [3–5].
    Molecular Diagnostics in Dermatology and Dermatopathology, 03/2011: pages 283-310;
Show more